--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q43.965M / 0.000--
US Stock MarketDetailed Quotes
ATBPF ANTIBE THERAPEUTICS INC
- 0.215600
- 0.0000000.00%
15min DelayClose Apr 8 16:00 ET
11.43MMarket Cap-842P/E (TTM)
0.000000High0.000000Low0Volume0.215600Open0.215600Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)53.01MShares0.88550052wk High0.60P/B11.43MFloat Cap0.11130052wk Low--Dividend TTM53.01MShs Float5.000000Historical High--Div YieldTTM0.00%Amplitude0.111300Historical Low--Avg Price1Lot Size
ANTIBE THERAPEUTICS INC Key Stats
ANTIBE THERAPEUTICS INC Earnings Date
Currency: CAD
Period
Q3 FY2024 Earnings
--
Revenue(YoY)
0.00
0.00%EPS(YoY)
-0.08
0.00%Analyst Rating
Apr 28, 2024
ANTIBE THERAPEUTICS INC Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CAD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg